Decision Support · Side-by-side

Entos vs Exscientia. Side by side.

Compare pricing, strengths, and use cases so it is easier to pick the right fit.

Browse alternatives Browse workflows

Change tools

Comparison Ready

Entos

Exscientia

Best overall

Neither Entos nor Exscientia is for everyday users—they are enterprise-grade drug discovery platforms for large pharma teams. Entos wins for computational chemists needing high-accuracy molecular predictions, while Exscientia leads for organizations that want end-to-end AI from target to clinical trial. The single biggest difference: Entos focuses on physics-based simulation accuracy, Exscientia on automating the full drug design-to-synthesis pipeline.

Entos

#4696 of 3,826 Web

Exscientia

#4220 of 3,826 Web

Scores at a glance

EntosExscientiaPractical Versatility

Onboarding Ease

Ecosystem Fit

Market Value

Choose Entos if

You lead a computational chemistry team at a pharma company and need the most accurate molecular property predictions available.
You have access to high-performance computing clusters and a budget for enterprise software.
You're willing to invest weeks in onboarding and training your team on quantum ML models.
You need to optimize lead compounds and can provide proprietary chemical libraries.

Choose Exscientia if

You're a VP of R&D at a large pharmaceutical company looking to outsource end-to-end AI drug discovery.
You want AI-designed molecules that have already reached human clinical trials.
You have a multi-million dollar partnership budget and a specific therapeutic target in mind.
You need patient stratification models for clinical trials, not just molecular design.

Key differences

Entos sells software you run on your own HPC; Exscientia sells a full-service partnership, not a product.
Entos focuses on physics-based simulation accuracy; Exscientia focuses on automating the design-make-test cycle.
Entos has published benchmarks showing higher accuracy than DFT; Exscientia has the first AI drugs in human trials.
Entos requires your team to do the work; Exscientia does the work for you as a partner.
Neither has a mobile app, API, or integrations—both are locked inside enterprise walls.
Pricing for both is unpublished and almost certainly out of reach for individuals or small teams.

Facts side by side

	Entos	Exscientia
Free plan
Mobile app
API access

Entos: strengths & weaknesses

Top-tier accuracy for predicting how molecules behave, beating traditional methods.
Cuts computing time and cost compared to standard quantum chemistry simulations.
Backed by PhD-level support to help you set up complex models.
No mobile app, no API, no integrations—you can't use it on a phone or connect it to other tools.
Requires high-performance computing (HPC) for big jobs, which most individuals don't have.
Steep learning curve even for scientists who aren't computational chemistry experts.
Pricing is hidden and likely very expensive—no option for a solo researcher or small startup.

Exscientia: strengths & weaknesses

First company to put AI-designed molecules into human trials—proven real-world impact.
Covers the entire drug discovery process from target ID to clinical trial design.
Uses real patient tissue data, making predictions more clinically relevant.
No mobile app, no API, no integrations—zero accessibility for individuals.
Extremely high cost and only available through strategic partnerships, not purchase.
Algorithms are completely proprietary and opaque—you can't customize or audit them.
Not available to individual researchers, academics, or small biotechs without a major deal.

Common questions

Can I use Entos or Exscientia on my phone?

No. Neither tool has a mobile app or any mobile-friendly interface. They are designed for desktop workstations or high-performance computing clusters.

Is Entos better than Exscientia for a small biotech startup?

Neither is a good fit. Entos requires significant HPC resources and a computational chemistry team. Exscientia only works through large partnerships. A small startup should look at cloud-based tools like Schrödinger or open-source options like DeepChem.

How much do Entos and Exscientia cost?

Both keep pricing private. Entos is an enterprise software license likely costing six figures annually. Exscientia operates through multi-year partnerships worth millions. Neither has a self-serve or subscription plan.

Which tool is easier to learn for a non-computational chemist?

Neither is easy. Entos has a steep learning curve even for chemists. Exscientia is not a tool you learn—it's a service where their scientists do the work. If you're not a computational chemist, Exscientia's partnership model is easier because you don't have to use the software yourself.

Do Entos or Exscientia have APIs I can integrate with my lab software?

No. Neither tool offers a public API or documented integrations. Entos may have custom API access for enterprise clients, but it's not standard. Exscientia's algorithms are entirely proprietary and not exposed via API.

Entos and Exscientia are powerful but inaccessible for everyday users—both are enterprise-only, lack mobile access and APIs, and cost far more than an individual can afford.

If you're reading this as an everyday user, neither Entos nor Exscientia is for you—they're enterprise-only platforms for big pharma. For drug discovery on a realistic budget, look at cloud-based tools like Schrödinger LiveDesign or open-source alternatives like RDKit. Save these two for when you have a dedicated team and a seven-figure budget.

Visit Entos Visit Exscientia

Detail pages: Entos · Exscientia

Entos

Exscientia

Free plan

Mobile app

API access